<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/css/uswds.min.css">
    <link rel="stylesheet" href="/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/html/titles/title10.html">
                                    Title 10
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/html/parts/10CFR35.html">Part 35
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 35.63  Determination of dosages of unsealed byproduct material
                            </h3>
                            <p class="depth1"><em>(a)</em> A licensee shall determine and record the activity of each dosage before medical use.</p><p class="depth1"><em>(b)</em> For a unit dosage, this determination must be made by--</p><p class="depth2"><em>(1)</em> Direct measurement of radioactivity; or</p><p class="depth2"><em>(2)</em> A decay correction, based on the activity or activity concentration determined by--</p><p class="depth3"><em>(i)</em> A manufacturer or preparer licensed under Sec. 32.72 of this chapter or equivalent Agreement State requirements; or</p><p class="depth3"><em>(ii)</em> An NRC or Agreement State licensee for use in research in accordance with a Radioactive Drug Research Committee-approved protocol or an Investigational New Drug (IND) protocol accepted by FDA; or</p><p class="depth3"><em>(iii)</em> A PET radioactive drug producer licensed under Sec. 30.32(j) of this chapter or equivalent Agreement State requirements.</p><p class="depth1"><em>(c)</em> For other than unit dosages, this determination must be made by--</p><p class="depth2"><em>(1)</em> Direct measurement of radioactivity;</p><p class="depth2"><em>(2)</em> Combination of measurement of radioactivity and mathematical calculations; or</p><p class="depth2"><em>(3)</em> Combination of volumetric measurements and mathematical calculations, based on the measurement made by:</p><p class="depth3"><em>(i)</em> A manufacturer or preparer licensed under Sec. 32.72 of this chapter or equivalent Agreement State requirements; or</p><p class="depth3"><em>(ii)</em> A PET radioactive drug producer licensed under Sec. 30.32(j) of this chapter or equivalent Agreement State requirements.</p><p class="depth1"><em>(d)</em> Unless otherwise directed by the authorized user, a licensee may not use a dosage if the dosage does not fall within the prescribed dosage range or if the dosage differs from the prescribed dosage by more than 20 percent.</p><p class="depth1"><em>(e)</em> A licensee shall retain a record of the dosage determination required by this section in accordance with Sec. 35.2063.
[67 FR 20370, Apr. 24, 2002, as amended at 72 FR 55931, Oct. 1, 2007]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
